The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVI Global Trust Regulatory News (AGT)

Share Price Information for AVI Global Trust (AGT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 247.00
Bid: 246.50
Ask: 247.00
Change: 2.00 (0.82%)
Spread: 0.50 (0.203%)
Open: 244.00
High: 247.00
Low: 243.50
Prev. Close: 245.00
AGT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Factsheet

13 Feb 2023 16:41

RNS Number : 7723P
AVI Global Trust PLC
13 February 2023
 

 

AVI GLOBAL TRUST PLC

 

Monthly Update

 

AVI Global Trust plc (the "Company") presents its Update, reporting performance figures for the month ended 31 January 2023.

 

This Monthly Newsletter is available on the Company's website at:

https://www.assetvalueinvestors.com/agt/content/uploads/2023/02/AGT-JAN-2023-1.pdf

 

Performance Total Return

 

This investment management report relates to performance figures to 31 January 2023.

 

Total Return (£)

Month

Calendar Yr

to date

1Y

5Y

10Y

AGT NAV1

6.0%

6.0%

2.2%

47.7%

137.6%

MSCI ACWI Ex US2

5.6%

5.6%

2.8%

23.6%

94.3%

MSCI ACWI1

4.7%

4.7%

0.3%

51.2%

184.3%

 

1

Source: Morningstar. All NAV figures are cum-fair values.

2

From 1st October 2013 the lead benchmark was changed to the MSCI ACWI ex US (£) Index. The investment management fee was changed to 0.7% of net assets and the performance related fee eliminated.

 

 

Manager's Comment

 

AVI Global Trust (AGT)'s NAV increased by +6.0% in January.

 

Markets have been ebullient, with the MSCI AC World index up +6.5% (in local currency) following a weak December and painful 2022. Every man and his dog knows that there's lots to worry about - from continued monetary policy tightening, to deteriorating consumer balance sheets and risks to corporate earnings. This, however, is how markets operate: they climb the wall of worry and dumbfound consensus opinion.

 

The consensus worries might well be right, and certainly the risks appear finely balanced, but markets are forward looking and can move higher despite this. That is not to say we are out of the woods yet - we are not - simply that the macroeconomic and broader market outlook remains deeply unclear, with a number of crosscurrents. As such we try to not let it impact our investment decisions - which are formed from the bottom up.

 

In this regard, it has been a busy start to the year for us at AVI, with a number of new positions having been added to the portfolio, and several existing positions boosted. The opportunity set is rich and varied. We have added materially to Spectrum Brand Holdings (now 3.1% of NAV), on which we elaborate below. We also continued to add to Nihon Kohden, the Japanese medical equipment company (3.6%) and built a basket of Japanese regional banks (2.4%), the share prices of which are yet to reflect the changing Japanese monetary policy environment. As well as this, we have increased our positions in Oakley Capital (7.9%) and Schibsted (7.6%) such that they are now the two largest positions. As such, for the first time in over a year, we have deployed a more substantial portion of our borrowings, with net gearing standing at 5.8% at the end of January. Whilst recognising that the future will be volatile and unpredictable, we feel selectively optimistic.

 

 

Christian Dior

 

Christian Dior ("CDI") was one of the strongest performers over the month, contributing +85bps to returns. The shares rose +16% - slightly behind the NAV (which rose +18%) - and as such the discount widened modestly from 13% to 15%.

 

The proximate cause for CDI's outperformance was China, with luxury goods companies key beneficiaries of the rapid re-opening of the economy and abandonment of zero-COVID policies. Industry analysts at Bain estimate that China's re-opening will see the global luxury industry grow at +6-8% in 2023, versus prior estimates of +3- 5%. On a recent earnings call alongside LVMH's full year results - published at the end of January - Mr. Arnault struck a similarly optimistic tone, declaring "we have every reason to be confident, indeed optimistic on China", with "quite spectacular" signs of things to come from Macau, where Chinese tourists can now travel.

 

In terms of LVMH's Q4/FY results, the business remains in rude health with Q4 sales organic growth of +9% well ahead of consensus. On the other hand, operating profit and margins were weaker than expected with much higher than anticipated marketing expenditure. Whilst interpreted as a negative by some, we believe this speaks to both LVMH's strength and the why mega-brands are likely to continue outperforming, with significant scale advantages in an industry with high fixed costs. In the short-term mega-brands go through periods where they underearn as spending runs far above "inflation opex", but in the long run the brand equity is increased and growth extended. Smaller mono-brands simply cannot compete with this, with our estimates indicating that Louis Vuitton's incremental opex in 2022 is of a similar magnitude to a smaller mono-brand's entire budget. If it is artistic creativity and a certain je ne sais quoi that creates brand strength, it is investment in the brand that maintains it.

 

As such we see LVMH as well placed to keep compounding earnings and driving NAV growth. On top of this there is further upside if and when the family decide to simplify the group structure.

 

Spectrum Brands Holdings

 

During the period we continued to boost our position in Spectrum Brands Holdings ("Spectrum Brands") - a US conglomerate where the protracted sale of its locks business to Assa Abloy has led the market to apply a punitively low value on its remaining businesses, the most attractive of which is a US pet chews business.

 

Over the last five years the company has taken considerable steps to simplify its strategy, selling non-core assets and focusing on its Pet Care and Homes & Gardens businesses. The most significant part of this process came in September 2021, with an agreement to sell their Hardware & Home Improvement division to Assa Abloy for an enterprise value of $4.3bn - which sent Spectrum Brands shares >$100.

 

However, shortly thereafter the Department of Justice ("DOJ") opposed the case on anti-trust grounds with the shares falling some -60% from their highs, allowing us to initiate a toe-hold position at $44 in the Autumn of 2022. Frustratingly, before we had fully built the position, Assa Abloy announced material concessions in the form of planned divestures which have increased the likelihood of the deal passing, sending Spectrum Brands shares +27% in one day. We have subsequently fully built the position with the shares in the low $60s.

 

Our thesis is simple: in a scenario where the deal goes through the shares are still far too cheap (trading at an implied 7x EBITDA vs. peers at 10-13x), and in a scenario where the deal is blocked there was a long-list of other potential buyers and a break fee payable equating to 13% of Spectrum Brand's market cap.

 

So where are we now? The ball is currently in the DOJ's court, with an announcement as to whether they will pursue litigation or accept Assa Abloy's remedies, due imminently. Failing an agreement at this stage, the case will move to trial in April, with a scheduled June completion.

 

Our base case is that this proceeds to court and that the deal ultimately gets approved. If approved, net proceeds of $3.5bn equate to 126% and 61% of Spectrum Brand's market cap and enterprise value, allowing the company to de-lever and return capital to shareholders through buybacks. Our estimates suggest they will have enough capital to buyback 45% of their outstanding shares at these levels, with current authorisation for 28%. A multiple of 10x EBITDA - in-line with closest peer Central Garden & Pet Company - yields a share price of $90 and +32% upside from here.

 

 

Contributors / Detractors (in GBP)

 

Largest Contributors

1- month contribution

bps

% Weight

KKR

94

5.9

Christian Dior

85

5.9

Schibsted ASA

84

7.6

Oakley Capital Investments

62

8.2

Brookfield/Short SPY

53

5.3

 

Largest Detractors

1- month contribution

bps

% Weight

Aker ASA

-27

6.6

Symphony International Holdings

-17

2.7

Third Point Investors/MF

-14

4.2

D'Ieteren

-7

2.3

VEF

-6

0.4

 

 

Link Company Matters Limited

Corporate Secretary

 

13 February 2023

 

LEI: 213800QUODCLWWRVI968

 

The content of the Company's web-pages and the content of any website or pages which may be accessed through hyperlinks on the Company's web-pages, other than the content of the Newsletter referred to above, is neither incorporated into nor forms part of the above announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCDZGMZVFGGFZM
Date   Source Headline
14th May 20241:05 pmRNSNet Asset Value(s)
13th May 20241:00 pmRNSNet Asset Value(s)
10th May 20244:43 pmRNSHolding(s) in Company
10th May 20241:35 pmRNSNet Asset Value(s)
9th May 20245:55 pmRNSTransaction in Own Shares
9th May 202412:46 pmRNSNet Asset Value(s)
8th May 20241:27 pmRNSNet Asset Value(s)
7th May 20241:18 pmRNSNet Asset Value(s)
3rd May 20242:08 pmRNSNet Asset Value(s)
2nd May 20245:43 pmRNSTransaction in Own Shares
2nd May 20241:55 pmRNSNet Asset Value(s)
1st May 20241:39 pmRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 202412:30 pmRNSNet Asset Value(s)
29th Apr 20241:34 pmRNSNet Asset Value(s)
26th Apr 202412:06 pmRNSNet Asset Value(s)
25th Apr 20241:57 pmRNSNet Asset Value(s)
24th Apr 202412:34 pmRNSNet Asset Value(s)
23rd Apr 20241:00 pmRNSNet Asset Value(s)
22nd Apr 202412:54 pmRNSNet Asset Value(s)
19th Apr 20245:35 pmRNSTransaction in Own Shares
19th Apr 20243:39 pmRNSNet Asset Value(s)
19th Apr 20247:00 amRNSCompliance with Market Abuse Regulation
18th Apr 20245:40 pmRNSTransaction in Own Shares
18th Apr 202412:18 pmRNSNet Asset Value(s)
17th Apr 202412:24 pmRNSNet Asset Value(s)
16th Apr 202412:31 pmRNSNet Asset Value(s)
15th Apr 202412:44 pmRNSNet Asset Value(s)
12th Apr 20245:30 pmRNSTransaction in Own Shares
12th Apr 20242:09 pmRNSNet Asset Value(s)
11th Apr 20245:49 pmRNSTransaction in Own Shares
11th Apr 202412:59 pmRNSNet Asset Value(s)
10th Apr 20245:44 pmRNSTransaction in Own Shares
10th Apr 20241:01 pmRNSNet Asset Value(s)
9th Apr 20245:40 pmRNSTransaction in Own Shares
9th Apr 20243:48 pmRNSMonthly Factsheet
9th Apr 202412:20 pmRNSNet Asset Value(s)
9th Apr 202411:56 amRNSDirector/PDMR Shareholding
8th Apr 20244:58 pmRNSDirector/PDMR Shareholding
8th Apr 202412:58 pmRNSNet Asset Value(s)
8th Apr 202412:53 pmRNSAppointment of Corporate Broker
8th Apr 202412:39 pmRNSListing Rule 15.6.8
5th Apr 20241:57 pmRNSNet Asset Value(s)
4th Apr 20245:32 pmRNSTransaction in Own Shares
4th Apr 20241:13 pmRNSNet Asset Value(s)
3rd Apr 20245:32 pmRNSTransaction in Own Shares
3rd Apr 20242:28 pmRNSNet Asset Value(s)
3rd Apr 20247:00 amRNSKepler Trust Intelligence: New Research
2nd Apr 20245:30 pmRNSTransaction in Own Shares
2nd Apr 20244:32 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.